10月13日，美农生物涨2.70%，成交额2.53亿元。两融数据显示，当日美农生物获融资买入额1952.94万 元，融资偿还1326.32万元，融资净买入626.62万元。截至10月13日，美农生物融资融券余额合计 5490.57万元。 分红方面，美农生物A股上市后累计派现1.54亿元。 机构持仓方面，截止2025年6月30日，美农生物十大流通股东中，国泰中证畜牧养殖ETF（159865）位 居第七大流通股东，持股82.14万股，为新进股东。 责任编辑：小浪快报 融资方面，美农生物当日融资买入1952.94万元。当前融资余额5490.57万元，占流通市值的3.39%，融 资余额超过近一年80%分位水平，处于高位。 融券方面，美农生物10月13日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00 元；融券余量0.00股，融券余额0.00元，超过近一年90%分位水平，处于高位。 资料显示，上海美农生物科技股份有限公司位于上海市嘉定区沥红路151号，成立日期1997年10月14 日，上市日期2022年6月17日，公司主营业务涉及饲料添加剂及酶解蛋白饲料原料的研发、生产、销 售。主营业务收入构 ...

证券日报网讯美农生物9月25日在互动平台回答投资者提问时表示，公司当前聚焦饲料添加剂和酶解蛋 白饲料原料的研发、生产和销售，暂不涉及疫苗的研发、生产和销售。公司将结合产业政策、行业发展 趋势、市场与客户需求等，持续迭代升级现有产品，研究开发高效、安全、环保型的饲料添加剂和酶解 蛋白饲料原料产品及其应用方案。 （文章来源：证券日报） ...

美农生物（301156.SZ）9月25日在投资者互动平台表示，尊敬的投资者，您好！公司当前聚焦饲料添加 剂和酶解蛋白饲料原料的研发、生产和销售，暂不涉及疫苗的研发、生产和销售。公司将结合产业政 策、行业发展趋势、市场与客户需求等，持续迭代升级现有产品，研究开发高效、安全、环保型的饲料 添加剂和酶解蛋白饲料原料产品及其应用方案。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：请问贵公司有没有考虑过开发动物添加剂疫苗，酶解 蛋白疫苗，动物直接注入，不用掺到饲料里，效果一样？ ...

格隆汇9月25日丨美农生物(301156.SZ)在互动平台表示，公司当前聚焦饲料添加剂和酶解蛋白饲料原料 的研发、生产和销售，暂不涉及疫苗的研发、生产和销售。公司将结合产业政策、行业发展趋势、市场 与客户需求等，持续迭代升级现有产品，研究开发高效、安全、环保型的饲料添加剂和酶解蛋白饲料原 料产品及其应用方案。 ...

Core Viewpoint - The company aims to deepen its domestic market presence while expanding internationally, focusing on customer development and product innovation in the feed additive sector [1] Group 1: Market Strategy - The company will adhere to a market strategy of "deepening domestic and breaking through internationally" in the second half of the year [1] - In the domestic market, the company focuses on core customer development and implements the "expanding one product project" to optimize customer procurement costs and maximize customer value [1] - The overseas market strategy involves a "go out, invite in" approach, with increased resource investment to enhance international market development [1] Group 2: Product Development - The company continues to focus on the pig, dairy cow, and poultry markets while also expanding into aquaculture and beef and sheep markets [1] - There will be an increased investment in R&D to develop efficient, safe, and environmentally friendly feed additives and enzymatic protein feed raw materials [1] - The "annual production of 100,000 tons of corn protein deep processing project" is expected to be completed and enter trial production this year, which will introduce corn concentrated protein and corn enzymatic protein products to the market [1] Group 3: Industry Impact - The new project is expected to positively address the current shortage of domestic feed protein resources and provide new growth points for the company's business development [1]

证券日报网讯 美农生物（301156）9月22日发布公告，在公司回答调研者提问时表示，公司始终坚 持"产品领先、价值服务、伙伴成长"的价值主张，紧紧围绕产品、市场、客户、效率等方面开展工作。 在产品端，公司践行"分种分品、全程营养"的产品战略，持续加大产品研发与创新投入，不断推出贴合 市场需求的新产品、新技术。从财务表达看，2025年上半年，公司主营饲料添加剂和酶解蛋白饲料原料 业务收入较上年同期均实现不同程度的增长，其中，饲料添加剂板块的肠道健康类产品表现尤为突出， 其收入同比增长超60%，是公司业绩增长的重要来源。在市场端，公司践行"深耕国内、突破国际"的市 场战略，组建了专业的国内、国际营销团队和价值服务团队，推动公司境内外业务双向发展，就财务结 果而言，公司境内外业务收入在今年上半年较上年同期皆实现不同程度的增长。在境内业务拓展方面， 公司实施变革创新，通过拓宽种类市场、做深客户市场、做强核心产品，推动境内业务逆势成长。在境 外业务拓展方面，公司一手抓"走出去"，持续开发新市场、扩张业务版图；一手抓"扎下去"，对现有市 场进行"价值深耕"，两力并举，提质增量，持续保持20%以上的增长。同时，公司通过不 ...

Group 1: Company Overview and Strategy - Shanghai Meinong Biological Technology Co., Ltd. focuses on "product leadership, value service, and partner growth" as its core value proposition [2] - The company implements a product strategy of "diversified species and products, full-process nutrition" to enhance product development and innovation [2][4] Group 2: Financial Performance - In the first half of 2025, the company reported revenue and profit growth, with feed additive revenue increasing by over 60% year-on-year, significantly contributing to overall performance [3] - Domestic and international business revenues both experienced growth, with international business revenue increasing by over 20% in the first half of 2025 [6] Group 3: Project Development - The company’s wholly-owned subsidiary, Leiling Meinong, is on track to complete its 100,000-ton corn protein deep processing project by the end of 2025 [3][4] - The project aims to alleviate the domestic protein resource shortage by utilizing corn by-products, aligning with national policies for diversified food supply systems [4][5] Group 4: Product Planning and Market Strategy - The project will launch corn concentrated protein and corn enzymatic protein products, enhancing nutritional value and meeting market demands [5] - The company has established a robust market network across over 20 provinces in China and several countries worldwide, supporting the promotion of its new products [5] Group 5: Research and Innovation - The company emphasizes innovation, achieving breakthroughs in feed additives and enzymatic protein feed materials, including a new gut health product and enhanced protein digestibility solutions [8][9] - Collaborative research with academic institutions aims to address industry challenges and expand product applications, creating new business opportunities [10]

Core Viewpoint - The company aims to deepen its domestic market presence while expanding internationally, focusing on customer development and product innovation in the feed additive sector [1] Group 1: Market Strategy - The company will adhere to a market strategy of "deepening domestic and breaking through internationally" [1] - In the domestic market, the focus will be on core customer development and implementing the "expanding one product project" to optimize procurement costs and maximize customer value [1] - The overseas market strategy includes "going out and inviting in," with increased resource investment to enhance international market development [1] Group 2: Product Development - The company will continue to focus on the pig, dairy cow, and poultry markets while also expanding into aquaculture and beef and sheep markets [1] - There will be an increased investment in R&D to develop efficient, safe, and environmentally friendly feed additives and hydrolyzed protein feed raw materials [1] - The "annual production of 100,000 tons of corn protein refined processing project" is expected to be completed and enter trial production this year, which will introduce corn concentrated protein and hydrolyzed corn protein products to the market [1] Group 3: Business Impact - The new project is anticipated to positively address the current shortage of domestic feed protein resources and provide new growth points for the company's business development [1]

Group 1 - The core viewpoint of the news highlights the financial performance and market activity of Meino Biological, indicating a positive trend in revenue and net profit growth [2][3] - As of August 28, Meino Biological's stock price increased by 2.19%, with a trading volume of 93.57 million yuan, and a net financing purchase of 1.43 million yuan [1] - The company has a total financing and securities balance of 46.28 million yuan, which accounts for 2.83% of its circulating market value, indicating a relatively high level compared to the past year [1] Group 2 - For the first half of 2025, Meino Biological reported a revenue of 236 million yuan, representing a year-on-year growth of 13.69%, and a net profit attributable to shareholders of 23.53 million yuan, up 17.68% year-on-year [2] - The company has distributed a total of 154 million yuan in dividends since its A-share listing [3] - As of June 30, 2025, the number of shareholders increased to 12,700, with an average of 5,878 circulating shares per person, a decrease of 33.43% from the previous period [2]

Group 1 - The core viewpoint of the articles highlights the strong performance of Meino Biological in the first half of 2025, with a revenue of 236 million yuan, a year-on-year increase of 13.69%, and a net profit attributable to shareholders of 23.527 million yuan, up 17.68% [1] - The company has maintained a robust growth in its international business, achieving over 20% growth in overseas revenue, amounting to 90.5632 million yuan in the first half of the year, with significant contributions from markets in Vietnam, Russia, Brazil, and several other countries [2] - Meino Biological aims to evolve into a global resource integration platform for the livestock industry, leveraging its international business network to export quality additives and introduce advanced products to China, enhancing the efficiency of domestic feed and breeding enterprises [3] Group 2 - The "Annual Production of 100,000 Tons of Corn Protein Refining Project" is progressing rapidly and is expected to begin trial production within the year, which will help alleviate the domestic shortage of protein resources in feed [4] - The new corn protein products, including corn concentrated protein and corn enzymatic protein, will significantly improve the nutritional value and digestibility of corn protein, meeting the high protein demands of poultry and aquaculture [4] - The company is actively applying for patents related to the production processes of its new products, indicating a commitment to innovation and product development [4]